About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
About
The Journal "Obstetrics and Gynecology"Journal HistoryAims and ScopePolicies on Conflict of Interest, Human and Animal Rights, and Informed ConsentEditorial ProcessData sharing statementAdvertising PolicyThe Process for Handling Cases Requiring Corrections, Retractions, and Editorial Expressions of ConcernEditorial BoardEditorial CounsilInformation for ProfessionalsNewsContacts
ArchiveEthical StandardsSubscription
For authors
InstructionsInformed consent policyContract offerEASE GuidelinesICJME CriteriaWAME Recommendations on ChatGPT and Chatbots in Relation to Scholarly Publications
Reviewing
Logout
Obstetrics and Gynegology2021№5
Role of abnormal vaginal microbiota...

Role of abnormal vaginal microbiota in the pathogenesis of recurrent lower urinary tract infection: a modern view of the problem

DOI
https://dx.doi.org/10.18565/aig.2021.5.40-46

Zaitsev A.V., Apolikhina I.A., Khodyreva L.A., Bernikov A.N., Kupriyanov Yu.A., Stroganov R.V., Arefyeva O.A., Teterina T.A.

1) A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia, Moscow, Russia; 2) Research Institute of Health Organization and Medical Management, Moscow Healthcare Department, Moscow, Russia; 3) S.I. Spasokukotsky City Clinical Hospital, Moscow Healthcare Department, Moscow, Russia; 4) Academician V.I. Kulakov National Medical Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of Russia, Moscow, Russia; 5) Department of Obstetrics, Gynecology, and Perinatology, I.M. Sechenov First Moscow State Medical University (Sechenov University), Ministry of Health of Russia, Moscow, Russia
The review is devoted to the problem of recurrent urinary tract infections (RUTIs) in women. It considers risk factors for RUTIs and the role of abnormal vaginal microbiota in this disease. E. coli have special virulence factors that cause urinary tract infection and colonization by adhesion to urothelial cells: the pronounced virulence of Type 1 factor (or Type 1 pili), which triggers an inflammatory response by attracting neutrophils to the bladder. Despite the fact that RUTIs are not considered a life threatening disease, they have a significant impact on quality of life, disabling effects on women's health, intimate and social relationships, self-rating and work ability, and also lead to irritability, fatigue, and inability to concentrate until depression develops. There are modern views on bacterial vaginosis and the associated new pathogenesis of RUTIs. The existing relationship between the factors of RUTIs, sexual practice, and the composition of the vaginal microbiome requires correction of the composition of the vaginal flora and the implementation of preventive measures and non-antimicrobial treatment. The major mechanisms of RUTI development are reinfection and bacterial persistence. Female RUTIs are associated with a steady upward entrance of the microflora from the periurethral region. Antibiotics are the most common treatment regimen for urinary tract infections (UTIs), at the same time they are becoming increasingly ineffective due to the emergence of antibiotic-resistant microorganisms. The global emergence of multidrug-resistant UPEC strains over the past decade highlights the need for alternative therapeutic and preventive strategies to combat UTIs.
Conclusion. Thus, a vicious circle is formed: the patient takes antibiotics often or even continuously for the treatment of cystitis, which leads to the development of vaginal dysbiosis, bacterial vaginosis, candidiasis, and vulvar and urethral discomfort. The presented results of clinical trials have confirmed the rationale, efficiency, and safety of taking vitamin D3, D-mannose, and proanthocyanidins in the treatment, prevention, and rehabilitation of patients with UTIs.

Keywords

urinary tract infection
cystitis
vaginal microbiota
bacterial vaginosis
proanthocyanidins
D-mannose
vitamin D3
Full text (in Russian)

References

  1. Aydin A., Ahmed K., Zaman I., Khan M.S., Dasgupta P. Recurrent urinary tract infections in women. Int. Urogynecol. J. 2015; 26(6): 795-804. https://dx.doi.org/10.1007/s00192-014-2569-5.
  2. Foxman B. Urinary tract infection syndromes: occurrence,recurrence, bacteriology, risk factors, and disease burden. Infect. Dis. Clin. North Am. 2014; 28(1): 1-13. https://dx.doi.org/10.1016/j.idc.2013.09.003.
  3. Nosseir S.B., Lind L.R., Winkler H.A. Recurrent uncomplicated urinary tract infections in women: a review. J. Womens Health (Larchmt). 2012; 21(3):347-54. https://dx.doi.org/10.1089/jwh.2011.3056.
  4. Lakeman M.M., Roovers J.P. Urinary tract infections in women with urogynaecological symptoms. Curr. Opin. Infect. Dis. 2016: 29(1): 92-7. https://dx.doi.org/10.1097/QCO.0000000000000229.
  5. Flower A., Bishop F.L., Lewith G. How women manage recurrent urinary tract infections: an analysis of postings on a popular web forum. BMC Fam. Pract. 2014; 15: 162. https://dx.doi.org/10.1186/1471-2296-15-162.
  6. Leydon G.M., Turner S., Smith H., Little P. Women’s views about management and cause of urinary tract infection: qualitative interview study. Br. Med. J. 2010; 340: c279. https://dx.doi.org/10.1136/bmj.c279.
  7. Graziottin A., Murina F., Gambini D., Taraborrelli S., Gardella B., Campo M.; VuNet Study Group. Vulvar pain: The revealing scenario of leading comorbidities in 1183 cases. Eur. J. Obstet. Gynecol. Reprod. Biol. 2020; 252: 50-5. https://dx.doi.org/10.1016/j.ejogrb.2020.05.052.
  8. Hooton T.M., Stamm W.E. Diagnosis and treatment of uncomplicated urinary tract infection. Infect. Dis. Clin. North Am. 1997; 11(3): 551-81. https://dx.doi.org/10.1016/s0891-5520(05)70373-1.
  9. European Association of Urology. Guidelines on urological infections. 2021.
  10. Hooton T.M., Stapleton A.E., Roberts P.L., Winter C., Scholes D., Bavendam T., Stamm W.E. Perineal anatomy and urine-voiding characteristics of young women with and without recurrent urinary tract infections. Clin. Infect. Dis. 1999; 29(6): 1600-1. https://dx.doi.org/10.1086/313528.
  11. Гвоздев М.Ю., Лоран О.Б., Гумин Л.М., Дьяков В.В. Транспозиция дистального отдела уретры в оперативном лечении рецидивирующей инфекции нижних мочевыводящих путей у женщин. Урология. 2000; 3: 24-7. [Gvozdev M.Yu., Loran O.B., Gumin L.M., D'iakov V.V. Transposition of the distal urethra in surgical treatment of recurrent lower urinary tract infection in women. Urology. 2000; 3: 24-7 (in Russian)].
  12. Деревянко Т.И. Влагалищная эктопия наружного отверстия уретры как одна из причин хронического рецидивирующего цистита у женщин: диагностика и лечение. Урология. 2009; 5: 18-21. [Derevianko T.I. Vaginal ectopia of urethra as a cause of chronic recurrent cystitis in women: diagnosis and treatment. Urology. 2009; 5: 18-21. (in Russian)].
  13. Gyftopoulos K. The aberrant urethral meatus as a possible aetiological factor of recurrent post-coital urinary infections in young women. Med. Hypotheses. 2018; 113: 6-8. https://dx.doi.org/10.1016/j.mehy.2018.02.005.
  14. Stapleton A.E. The vaginal microbiota and urinary tract infection. Microbiol. Spectr. 2016; 4(6): 10.1128/microbiolspec.UTI-0025-2016. https://dx.doi.org/10.1128/microbiolspec.UTI-0025-2016.
  15. Pfau A., Sacks T. The bacterial flora of the vaginal vestibule, urethra and vagina in premenopausal women with recurrent urinary tract infections. J. Urol. 1981; 126(5): 630-4. https://dx.doi.org/10.1016/s0022-5347(17)54661-3.
  16. Tachedjian G., Aldunate M., Bradshaw C.S., Cone R.A. The role of lactic acid production by probiotic Lactobacillus species in vaginal health. Res. Microbiol. 2017; 168(9-10): 782-92. https://dx.doi.org/10.1016/j.resmic.2017.04.001.
  17. Navas-Nacher E.L., Dardick F., Venegas M.F., Anderson B.E., Schaeffer A.J., Duncan J.L. Relatedness of Escherichia coli colonizing women longitudinally. Mol. Urol. 2001; 5(1): 31-6. https://dx.doi.org/10.1089/109153601750124285.
  18. Ravel J., Gajer P., Abdo Z., Schneider G.M., Koenig S.S.K., McCulle S.L. et al. Vaginal microbiome of reproductive-age women. Proc. Natl. Acad. Sci. USA. 2011; 108; (Suppl. 1): 4680-7. https://dx.doi.org/10.1073/pnas.1002611107.
  19. Соловьева А.В., Гаче В. Нарушения биоценоза влагалища у женщин репродуктивного возраста. Акушерство и инекология. 2017; 4: 126-31. [Solovyeva A.V., Gache V. Impaired vaginal biocenosis in reproductive-aged women. Obstetrics and Gynecology. 2017; 4: 126-31. (in Russian)]. https://dx.doi.org/10.18565/aig.2017.4.126-31.
  20. van de Wijgert J.H.H.M. The vaginal microbiome and sexually transmitted infections are interlinked: Consequences for treatment and prevention. PLoS Med. 2017; 14(12): e1002478. https://dx.doi.org/10.1371/journal.pmed.1002478.
  21. Harmanli O.H., Cheng G.Y., Nyirjesy P., Chatwani A., Gaughan J.P. Urinary tract infections in women with bacterial vaginosis. Obstetю Gynecol. 2000; 95(5): 710-2. https://dx.doi.org/10.1016/s0029-7844(99)00632-8.
  22. Hillebrand L., Harmanli O.H., Whiteman V., Khandelwal M. Urinary tract infections in pregnant women with bacterial vaginosis. Am. J. Obstet. Gynecol. 2002; 186(5): 916-7. https://dx.doi.org/10.1067/mob.2002.123987.
  23. Ильина И.Ю., Доброхотова Ю.Э. Бактериальный вагиноз. Возможные пути решения проблемы. РМЖ. 2020; 11: 75-8. [Ilina I.Yu., Dobrokhotova Yu.E. Bacterial vaginosis. Possible solutions to the problem. RMJ. 2020; 11: 75-8. (in Russian)].
  24. Аполихина И.А., Эфендиева З.Н. Современные направления в лечении бактериального вагиноза. Акушерство и гинекология. 2019; 12: 193-6. [Apolikhina I.A., Afendieva Z.N. Current trends in the management of bacterial vaginosis. Obstetrics and Gynecology. 2019; 12: 193-6. (in Russian)]. 10.1128/microbiolspec.UTI-0025-2016. 10.18565/aig.2019.12.193-196.
  25. Jung H., Peters R.P.H., Lombaard H., Ehlers M.M. Growth forms of Gardnerella spp. and Lactobacillus spp. on vaginal cells. Front. Cell. Infect. Microbiol. 2020; 10: 71. https://dx.doi.org/10.3389/fcimb.2020.00071.
  26. Muzny C.A., Taylor C.M., Swords W.E., Tamhane A., Chattopadhyay D., Cerca N., Schwebke J.R. An updated conceptual model on the pathogenesis of bacterial vaginosis. J. Infect. Dis. 2019; 220(9): 1399-405. https://dx.doi.org/10.1093/infdis/jiz342.
  27. Vaneechoutte M., Guschin A., Van Simaey L., Gansemans Y., Van Nieuwerburgh F., Cools P. Emended description of Gardnerella vaginalis and description of Gardnerella leopoldii sp. nov., Gardnerella piotii sp. nov. and Gardnerella swidsinskii sp. nov., with delineation of 13 genomic species within the genus Gardnerella. Int. J. Syst. Evol. Microbiol. 2019; 69(3): 679-87. https://dx.doi.org/10.1099/ijsem.0.003200.
  28. O'Brien V.P., Hannan T.J., Nielsen H.V., Hultgren S.J. Drug and vaccine development for the treatment and prevention of urinary tract infections. Microbiol. Spectr. 2016; 4(1): 10.1128/microbiolspec.UTI-0013-2012. https://dx.doi.org/10.1128/microbiolspec.UTI-0013-2012.
  29. Lewis A.L., Gilbert N.M. Roles of the vagina and the vaginal microbiota in urinary tract infection: evidence from clinical correlations and experimental models. GMS Infect. Dis. 2020; 8: Doc02. https://dx.doi.org/10.3205/id000046.
  30. Ratten L.K., Plummer E.L., Murray G.L., Danielewski J., Fairley C.K., Garland S.M. et al. Sex is associated with the persistence of non-optimal vaginal microbiota following treatment for bacterial vaginosis: a prospective cohort study. BJOG. 2021; 128(4): 756-67. https://dx.doi.org/10.1111/1471-0528.16430.
  31. Reed J.F. Jr. Urethral-hymenal fusion: a cause of chronic adult female cystitis. J. Urol. 1970; 103(4): 441-6. https://dx.doi.org/10.1016/s0022-5347(17)61977-3.
  32. Гвоздев М.Ю. Транспозиция уретры: особенности и отдаленные результаты. Дайджест урологии. 2018; 2: 18-24. [Gvozdev M.Yu. Transposition of the urethra: particularities and long-term results. Urodigest. 2018; 2: 18-24. (in Russian)].
  33. Bergamin P.A., Kiosoglous A.J. Non-surgical management of recurrent UTIs. Transl. Androl. Urol. 2017; 6(Suppl. 2): S142-52. https://dx.doi.org/10.21037/tau.2017.06.09.
  34. Morrill S., Gilbert N.M., Lewis A.L. Gardnerella vaginalis as a cause of bacterial vaginosis: appraisal of the evidence from in vivo models. Front. Cell. Infect. Microbiol. 2020; 10: 168. https://dx.doi.org/10.3389/fcimb.2020.00168.
  35. Кульчавеня Е.В., Бреусов А.А. Рецидивирующий цистит и бактериальный вагиноз: как избежать полипрагмазии. Гинекология. 2020; 22(4): 17-21. [Kulchavenya E.V., Breusoff A.A. Recurrent cystitis and bacterial vaginosis: how to avoid polypharmacy. Gynecology. 2020; 22(4): 17-21. (in Russian)]. https://dx.doi.org/ https://dx.doi.org/10.26442/20795696.2020.4.200275.
  36. Schaeffer A.J., Amundsen S.K., Jones J.M. Effect of carbo-hydrates on adherence of Escherichia coli to human urinary tract epithelial cells. Infec.t Immun. 1980; 30: 531-7.
  37. Schaeffer A.J., Chmiel J.S., Duncan J.L., Falkowski W.S. Mannose-sensitive adherence of Escherichia coli to epithelial cells from women with recurrent urinary tract infections. J. Urol. 1984; 131(5): 906-10. https://dx.doi.org/10.1016/s0022-5347(17)50706-5.
  38. Kranjčec B., Papeš D., Altarac S. D-mannose powder for prophylaxis of recurrent urinary tract infections in women: a randomized clinical trial. World J. Urol. 2014; 32: 79-84. https://dx.doi.org/10.1007/s00345-013-1091-6.
  39. Domenici L., Monti M., Bracchi C., Giorgini M., Colagiovanni V., Muzii L., Panici P.B. D-Mannose: a promising support for acute urinary tract infections in women. A pilot study. Eur. Rev. Med. Pharmacol. Sci. 2016;20(13): 2920-5.
  40. Кузьменко А.В., Кузьменко В.В., Гяургиев Т.А. Эффективность комбинированной антибактериально-пребиотической терапии в сочетании с D-маннозой у женщин с неосложненной инфекцией нижних мочевых путей. Урология. 2019; 6: 38-43. [Kuzmenko A.V., Kuzmenko V.V., Gyaurgiev T.A.
  41. Efficacy of combined antibacterial-prebiotic therapy in combination with D-mannose in women with uncomplicated lower urinary tract infection. Urology. 2019; 6: 38-43. (in Russian)].
  42. Franssen M., Cook J., Robinson J., Williams N., Glogowska M., Yang Y. et al. D-MannosE to prevent recurrent urinary tract InfecTions (MERIT): protocol for a randomised controlled trial. BMJ Open. 2021; 11(1): e037128. https://dx.doi.org/10.1136/bmjopen-2020-037128.
  43. Sobota A.E. Inhibition of bacterial adherence by cranberry juice: potential use for the treatment of urinary tract infections. J. Urol. 1984; 131(5): 1013-6. https://dx.doi.org/10.1016/S0022-5347 (17) 50751-X.
  44. Jepson R.G., Mihaljevic L., Graig J. Cranberries for preventing urinary tract infections. Cochrane Database Syst. Rev. 2004; (1): CD001321. https://dx.doi.org/10.1002/14651858.CD001321.
  45. Lenger S.M., Bradley M.S., Thomas D.A., Bertolet M.H., Lowder J.L., Sutcliffe S. D-mannose vs other agents for recurrent urinary tract infection prevention in adult women: a systematic review and meta-analysis. Am. J. Obstet. Gynecol. 2020; 223(2): 265. e1-265. e13. https://dx.doi.org/10.1016/j.ajog.2020.05.048.
  46. Hertting O., Holm Å., Lüthje P., Brauner H., Dyrdak R., Jonasson A.F. et al. Vitamin D induction of the human antimicrobial peptide cathelicidin in the urinary bladder. PLoS One. 2010; 5: e15580. https://dx.doi.org/10.1371/journal.pone.0015580.

Received 28.04.2021

Accepted 17.05.2021

About the Authors

Andrew V. Zaitcev, Dr. Med. Sci., Professor at the Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia. Tel.: +7(926)104-65-56. E-mail: zaitcevandrew@mail.ru. ORCID: 0000-0003-3044-1424. 127473, Russia, Moscow, Delegatskaya str., 20/1.
Inna A. Apolikhina, MD, PhD, professor, Head of the Department of Aesthetic gynecology and Rehabilitation, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia; Professor of the Department of Obstetrics, Gynecology, Perinatology and Reproductology, Institute of Professional Education, I.M. Sechenov First Moscow State Medical University, Ministry of Health of Russia; President of Association of Aesthetic Gynecology Specialists (AAGS),
President of European Association for Genital Aesthetic Medicine and Plastic Surgery (EAGAMPS). Tel.: +7(495)735-10-55. ORCHID: 0000-0002-4581-6295.
117997, Russia, Moscow, Akademika Oparina str., 4.
Luybov A. Khodyreva, Ph.D, Head of the Department of organizational and methodical support for the urology, Research Institute for the Organization of Healthcare and Medical Management, Moscow Department of Healthcare. ORCID: 0000-0002-0751-4982. 115088, Russia, Moscow, Sharikopodshipnikovskaya str., 9.
Alexander N. Bernikov, PhD, Associate professor at the Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health
of Russia. ORCID: 0000-0001-8361-585Х. 127473, Russia, Moscow, Delegatskaya str., 20/1.
Yuriy A. Kupriyanov, PhD, MD, assistant at the Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia. ORCID: 0000-0002-5807-7591. 127473, Russia, Moscow, Delegatskaya str., 20/1.
Roman V. Stroganov, PhD, assistant at the Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia.
ORCID: 0000-0002-5529-1787. 127473, Russia, Moscow, Delegatskaya str., 20/1.
Oksana A. Arefyeva, PhD, assistant at the Department of Urology, A.I. Evdokimov Moscow State University of Medicine and Dentistry, Ministry of Health of Russia.
ORCID: 0000-0003-2309-2094. 127473, Russia, Moscow, Delegatskaya str., 20/1.
Tatiana A. Teterina, MD, PhD, gynecologist of the Department of Aesthetic Gynecology and Rehabilitation, V.I. Kulakov National Medical Research Center for Obstetrics, Gynecology and Perinatology, Ministry of Health of Russia. Tel.: +7(495)735-10-55. E-mail: t_teterina@oparina4.ru. ORCHID: 0000-0003-0990-2302.
117997, Russia, Moscow, Akademika Oparina str., 4.

For citation: Zaitsev A.V., Apolikhina I.A., Khodyreva L.A., Bernikov A.N., Kupriyanov Yu.A., Stroganov R.V., Arefyeva O.A., Teterina T.A. Role of abnormal vaginal microbiota in the pathogenesis of recurrent lower urinary tract infection: a modern view of the problem.
Akusherstvo i Ginekologiya/Obstetrics and Gynecology. 2021; 5: 40-46 (in Russian)
https://dx.doi.org/10.18565/aig.2021.5.40-46

Similar Articles

№5 / 2023
Shalina R.I., Anankina A.A., Osipov A.N., Titov V.Yu., Spiridonov D.S.
Sensitivity and specificity of plasma nitric oxide metabolites for the diagnosis of intrauterine pneumonia in preterm prelabor rupture of membranes
№9 / 2021
Uruimagova A.T., Prilepskaya V.N., Mezhevitinova E.A., Donnikov A.E., Attoeva D.I.
Dysbiotic disorders and innate immunity indices in bacterial vaginosis
№7 / 2023
Tyutyunnik V.L., Mikhailova O.I., Kan N.E., Mirzabekova D.D.
Complex therapy of bacterial vaginosis during pregnancy
№5 / 2024
Apolikhina I.A., Boris D.A., Iurova M.V., Gorbunova Е.А., Teterina Т.А.
Possibilities of antibacterial therapy in patients with mixed infections of the vagina and cervix: the results of the Flora Centrum study
№3 / 2023
Kachalina O.V., Matuzkova A.A.
Activated glycyrrhizic acid in the combination treatment of patients with vaginitis and dysbiosis:results of a multicenter study
By continuing to use our site, you consent to the processing of cookies that ensure the proper functioning of the site.